Exploring the Relationship between SLC30A8 Gene Polymorphism and Type 2 Diabetes Susceptibility in District Vehari, Pakistan
DOI:
https://doi.org/10.53560/PPASB(61-2)1056Keywords:
Genotype, rs13266634, SLC30A8, Single Nucleotide Polymorphism, Type 2 Diabetes MellitusAbstract
Type 2 diabetes mellitus (T2DM) is estimated to afflict 537 million individuals globally and has reached an epidemic scale. These global estimates are to develop innovative preventive and treatment methods and to put these methods into action. To investigate if SLC30A8 gene polymorphisms can be used to predict the onset of T2DM in residents of Punjab, Pakistan, two groups were established based on prospective follow-up of appropriate population samples. Males made up 29.6% and women 70.4% of the T2DM unit. Deoxyribonucleic acid (DNA) was separated. Polymerase chain reaction or PCR was used for genotyping, and real-time PCR was then conducted. The statistical analysis was performed utilizing the statistical package SPSS 16.0 software program. The SLC30A8 gene genotype TT rs13266634 was linked to an increased risk of type 2 diabetes mellitus (T2DM) (relative risk — RR 1.51, 95% confidence interval — CI 1.11 – 2.05, p = 0.008). A protective benefit against T2DM was linked to the SLC30A8 gene's CC genotype, rs13266634 (RR 0.57, 95% CI 0.35 – 0.92, p = 0.026). The T2DM group comprised 442 individuals in the District Vehari. The average age at the time of the initial screening was 56.2 ± 6.7 years. 531 individuals without diabetes were chosen to serve as controls; their average age was 56.1 ± 7.1 years. In the control group, the frequencies of single nucleotide polymorphisms (abbreviated as SNP) match the expected frequencies as per the Hardy–Weinberg equilibrium. The SLC30A8 gene's rs13266634 polymorphism shows its correlation with the likelihood of developing T2DM and can be a potential candidate for a diabetes risk score.
References
O. Tariq, C. Rosten, and J. Huber. Cultural Influences on Making Nutritional Adjustments in Type 2 Diabetes in Pakistan: The Perspectives of People Living with Diabetes and Their Family Members. Qualitative Health Research 34(6): 562-578 (2024).
S. Azeem, U. Khan, and A. Liaquat. The increasing rate of diabetes in Pakistan: A silent killer. Annals of Medicine and Surgery 79: 103901 (2022).
Grover, A. Sharma, K. Gautam, S. Gautam, S. Gulati, M. Singh, and S. K. Diabetes and its complications: Therapies available, anticipated and aspired. Current Diabetes Reviews 17(4): 397-420 (2021).
F. Hua. New insights into diabetes mellitus and its complications: a narrative review. Annals of Translational Medicine 8(24): 1689 (2020).
R. Taheri, F. Kazerouni, R. Mirfakhraei, S. Kalbasi, S.Z. Shahrokhi, and A. Rahimipour. The influence of SLC22A3 rs543159 and rs1317652 genetic variants on metformin therapeutic efficacy in newly diagnosed patients with type 2 diabetes mellitus: 25 weeks follow-up study. Gene 823: 146382 (2022).
A. Jamwal. Systematic Review on Medicaments Used in Management of Diabetes Mellitus. International Journal of Pharmacy and Pharmaceutical Sciences 12(8): 21-29 (2020).
E. Ahmad, S. Lim, R. Lamptey, D. R. Webb, and M. J. Davies. Type 2 diabetes. The Lancet 400(10365): 1803-1820 (2022).
I.I. Dedov, M.V. Shestakova, O.K. Vikulova, A.V. Zheleznyakova, and M.A. Isakov. Epidemiological characteristics of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the Federal diabetes register data of 01.01.2021. Diabetes Mellitus 24(3): 204-221 (2021).
N. Sikhayeva, A. Iskakova, N. Saigi-Morgui, E. Zholdybaeva, C.B. Eap, and E. Ramanculov. Association between 28 single nucleotide polymorphisms and type 2 diabetes mellitus in the Kazakh population: a case-control study. BMC Medical Genetics 18(1): 1-13 (2017).
E.S. Mel’nikova, S.V. Mustafina, O.D. Rymar, A.A. Ivanova, L.V. Shcherbakova, M. Bobak, S.K. Maljutina, M.I. Voevoda, and V.N. Maksimov. Association of polymorphisms of genes SLC30A8 and MC4R with the prognosis of the development of type 2 diabetes mellitus. Diabetes Mellitus 25(3): 215-225 (2022).
S. Suthon, and W. Tangjittipokin. Mechanisms and Physiological Roles of Polymorphisms in Gestational Diabetes Mellitus. International Journal of Molecular Sciences 25(4): 2039 (2024).
R. Giacconi, M. Malavolta, L. Chiodi, G. Boccoli, L. Costarelli, A.R. Bonfigli, R. Galeazzi, F. Piacenza, A. Basso, N. Gasparini, L. Nisi, R. Testa, and M. Provinciali. ZnT8 Arg325Trp polymorphism influences zinc transporter expression and cytokine production in PBMCs from patients with diabetes. Diabetes Research and Clinical Practice 144: 102-110 (2018).
H. Koepsell. General overview of organic cation transporters in brain. Organic Cation Transporters in the Central Nervous System 266: 1-39 (2021).
P. Benny, H.J. Ahn, J. Burlingame, M.J. Lee, C. Miller, J. Chen, and J. Urschitz. Genetic risk factors associated with gestational diabetes in a multi-ethnic population. Plos One 16(12): 0261137 (2021).
Q. Zeng, B. Tan, F. Han, X. Huang, J. Huang, Y. Wei, and R Guo. Association of solute carrier family 30 A8 zinc transporter gene variations with gestational diabetes mellitus risk in a Chinese population. Front Endocrinol 14: 1159714 (2023).
H. Sun, P. Saeedi, S. Karuranga, M. Pinkepank, K. Ogurtsova, B.B. Duncan, ... and D.J. Magliano. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice 183: 109119 (2022).
T. Jamshaid. Diabetes Mellitus–The Epidemic of 21 Century. Esculapio-Journal of Services Institute of Medical Sciences 19(01): 1-2 (2023).
K.G. Jhaveri. Linagliptin and metformin in Indian patients with type 2 diabetes: Safety and efficacy study. International Journal of Life Sciences, Biotechnology and Pharma Research 12(3):1587-1591 (2023).
F. Chimienti, S. Devergnas, A. Favier, and M. Seve. Identification and cloning of a β-cell–specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 53(9): 2330-2337 (2004).
F. Chimienti, S. Devergnas, F. Pattou, F. Schuit, R. Garcia-Cuenca, B. Vandewalle, ... and M. Seve. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. Journal of Cell Science 119(20): 4199-4206 (2006).
R. Sladek, G. Rocheleau, J. Rung, C. Dina, L. Shen, D. Serre, P. Boutin, D. Vincent, A. Belisle, S. Hadjadj, B. Balkau, B. Heude, G. Charpentier, T.J. Hudson, A. Montpetit, A.V. Pshezhetsky, M. Prentki, B.I. Posner, D.J. Balding, D. Meyre, C. Polychronakos, and P. Froguel. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445(7130): 881-885 (2007).
K. Baptiste-Roberts, B.B. Barone, T.L. Gary, S.H. Golden, L.M. Wilson, E.B. Bass, and W.K. Nicholson. Risk factors for type 2 diabetes among women with gestational diabetes: a systematic review. The American Journal of Medicine 122(3): 207-214 (2009).
Z. Guo, D. Kasinathan, C. Merriman, M. Nakayama, H. Li, H. Li, C. Xu, G.W. Wong, L. Yu, M.L. Golson, and D. Fu. Cell-Surface Autoantibody Targets Zinc Transporter-8 (ZnT8) for In Vivo β-Cell Imaging and Islet-Specific Therapies. Diabetes 72(2): 184-195 (2023).
K. Siddiqui, S.S. Nawaz, A.A. Alfadda, and M. Mujammami. Islet Autoantibodies to Pancreatic Insulin-Producing Beta Cells in Adolescent and Adults with Type 1 Diabetes Mellitus: A Cross-Sectional Study. Diagnostics 13(10): 1736 (2023).
R.N. Weijers. Three-dimensional structure of β-cell-specific zinc transporter, ZnT-8, predicted from the type 2 diabetes-associated gene variant SLC30A8 R325W. Diabetology & Metabolic Syndrome 2(1): 1-8 (2010).
C.P. Barragán-Álvarez, E. Padilla-Camberos, N.F. Díaz, A. Cota-Coronado, C. Hernández-Jiménez, C.C. Bravo-Reyna, and N.E. Díaz-Martínez. Loss of Znt8 function in diabetes mellitus: risk or benefit? Molecular and Cellular Biochemistry 476(7): 2703-2718 (2021).
S. Sarkar, G. Thakur, and M. Bhattacharya. A brief study of genes vital for diabetes and their relationship. In Contemporary Medical Biotechnology Research for Human Health 41-48 (2022).
M.J. Daniels, M. Jagielnicki, and M. Yeager. Structure/Function analysis of human ZnT8 (SLC30A8): A diabetes risk factor and zinc transporter. Current Research in Structural Biology 2: 144-155 (2020).
B.N. Cortez, H. Pan, S. Hinthorn, H. Sun, N. Neretti, A.L. Gloyn, and C. Aguayo-Mazzucato. Heterogeneity of increased biological age in type 2 diabetes correlates with differential tissue DNA methylation, biological variables, and pharmacological treatments. GeroScience 46(2): 2441-2461 (2024).
Y. Horikawa, K. Miyake, K. Yasuda, M. Enya, Y. Hirota, K. Yamagata, Y. Hinokio, Y. Oka, N. Lwasaki, Y. Lwamoto, Y. Yamada, Y. Seino, H. Maegawa, A. Kashiwagi, K. Yamamoto, K. Tokunaga, J. Takeda, and M. Kasuga. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. The Journal of Clinical Endocrinology & Metabolism 93(8): 3136-3141 (2008).
I. Bartel, M. Koszarska, N. Strzałkowska, N.T. Tzvetkov, D. Wang, J.O. Horbańczuk, A. Wierzbicka, A.G. Atanasov, and A. Jóźwik. Cyanidin-3-O-glucoside as a Nutrigenomic Factor in Type 2 Diabetes and Its Prominent Impact on Health. International Journal of Molecular Sciences 24(11): 9765 (2023).
S.H. Kwak, S. Srinivasan, L. Chen, J. Todd, J.M. Mercader, E.T. Jensen, J. Divers, A.K. Mottl, C. Pihoker, R.G. Gandica, L.M. Laffel, E. Isganatitis, M.W. Haymond, L.L. Levitsky, T.I. Pollin, J.C. Florez, J. Flannick, and Progress in Diabetes Genetics in Youth (ProDiGY) consortium. Genetic architecture and biology of youth-onset type 2 diabetes. Nature Metabolism 1-12 (2024).
J. Zhen, Y. Gu, P. Wang, W. Wang, S. Bian, S. Huang, H. Liang, M. Huang, Y. Yu, Q. Chen, G. Jiang, X. Qui, L.Xiong, and S. Liu. Genome-wide association and Mendelian randomisation analysis among 30,699 Chinese pregnant women identifies novel genetic and molecular risk factors for gestational diabetes and glycaemic traits. Diabetologia 67: 703-713 (2024).
L. Cheng, D. Zhang, L. Zhou, J. Zhao, and B. Chen. Association between SLC30A8 rs13266634 polymorphism and type 2 diabetes risk: a meta-analysis. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 21: 2178 (2015).
I. Drake, G. Hindy, U. Ericson, and M. Orho-Melander. A prospective study of dietary and supplemental zinc intake and risk of type 2 diabetes depending on genetic variation in SLC30A8. Genes & Nutrition 12: 30 (2017).
S. Syarifuddin, and W. Samosir. Characteristics of types of diabetes mellitus II in regional general hospital than rondahaim, simalungun district. Medalion Journal: Medical Research, Nursing, Health and Midwife Participation 3(4): 144-148 (2022).
S. Akhtar, J.A. Nasir, T. Abbas, and A. Sarwar. Diabetes in Pakistan: A systematic review and meta-analysis. Pakistan Journal of Medical Sciences 35(4): 1173 (2019).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Upon acceptance of an article, its copyright will be assigned to the Pakistan Academy of Sciences.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY). Allows users to: copy the article and distribute; abstracts, create extracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation); include in a collective work (such as an anthology); and text or data mine the article. These uses are permitted even for commercial purposes, provided the user: includes a link to the license; indicates if changes were made; gives appropriate credit to the author(s) (with a link to the formal publication through the relevant DOI); and does not represent the author(s) as endorsing the adaptation of the article or modify the article in such a way as to damage the authors' honor or reputation.
